Greenphire CEO Selected as Finalist in Ernst & Young Awards
Friday, May 17, 2013
CEO Sam Whitaker has been selected as a finalist for the Ernst & Young Entrepreneur of the Year Awards 2013 in the Greater Philadelphia region.
Preclinical Tests Shows Agent Stops “Slippery” Proteins from Binding, Causing Ewing Sarcoma
Friday, May 17, 2013
Some tumors regressed to the point that cancer cells could not be detected microscopically.
Team Successfully Converts Human Skin Cells into Embryonic Stem Cells
Friday, May 17, 2013
The breakthrough marks the first time human stem cells have been produced via nuclear transfer and follows several unsuccessful attempts by research groups worldwide.
Nuvo Granted U.S. Patent for Using WF10
Thursday, May 16, 2013
New derivative formulations for the treatment of Allergic Rhinitis and Allergic Asthma.
Results of the ROTAVAC Rotavirus Vaccine Study in India
Thursday, May 16, 2013
Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health.
Vermillion Announces Closing of Equity Financing
Thursday, May 16, 2013
Company to increase the number of directors of the Company from six to eight persons.
Flu in Pregnancy May Quadruple Child’s Risk for Bipolar Disorder
Thursday, May 16, 2013
NIH-funded study adds to evidence of overlap with Schizophrenia.
Nanostart-holding New Asia Investments Invests in Breakthrough Water Projects
Thursday, May 16, 2013
Bringing affordable, clean and safe water to the Southeast Asia region based on a new model of de-centralized water treatment plants.
Vermillion Supports First World Ovarian Cancer Day
Thursday, May 16, 2013
Vermillion offers women new hope with OVA1, a FDA-cleared test designed to aid in the prediction of malignancy prior to surgery on an ovarian mass.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 21 - 30 of 22214 |
|
|
